Serina Therapeutics Statistics

Total Valuation

SER has a market cap or net worth of $54.99 million. The enterprise value is $50.11 million.

Market Cap	54.99M
Enterprise Value	50.11M

Important Dates

The last earnings date was Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

SER has 10.25 million shares outstanding. The number of shares has increased by 138.29% in one year.

Current Share Class	10.25M
Shares Outstanding	10.25M
Shares Change (YoY)	+138.29%
Shares Change (QoQ)	+2.54%
Owned by Insiders (%)	29.25%
Owned by Institutions (%)	6.35%
Float	2.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	430.52
Forward PS	n/a
PB Ratio	0.03
P/TBV Ratio	31.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	385.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.11.

Current Ratio	2.24
Quick Ratio	1.70
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-39.56

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-132.37%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-386.77%
Revenue Per Employee	$10,000
Profits Per Employee	-$968,538
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.91%
50-Day Moving Average	5.65
200-Day Moving Average	5.31
Relative Strength Index (RSI)	49.80
Average Volume (20 Days)	25,359

Short Selling Information

The latest short interest is 51,313, so 0.50% of the outstanding shares have been sold short.

Short Interest	51,313
Short Previous Month	32,356
Short % of Shares Out	0.50%
Short % of Float	1.84%
Short Ratio (days to cover)	1.48

Income Statement

In the last 12 months, SER had revenue of $130,000 and -$12.59 million in losses. Loss per share was -$1.33.

Revenue	130,000
Gross Profit	-7.35M
Operating Income	-20.81M
Pretax Income	-890,146
Net Income	-12.59M
EBITDA	-20.66M
EBIT	-20.81M
Loss Per Share	-$1.33

Full Income Statement

Balance Sheet

The company has $6.04 million in cash and $185,000 in debt, giving a net cash position of $5.86 million or $0.57 per share.

Cash & Cash Equivalents	6.04M
Total Debt	185,000
Net Cash	5.86M
Net Cash Per Share	$0.57
Equity (Book Value)	1.65M
Book Value Per Share	177.62
Working Capital	4.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.62 million and capital expenditures -$54,000, giving a free cash flow of -$15.68 million.

Operating Cash Flow	-15.62M
Capital Expenditures	-54,000
Free Cash Flow	-15.68M
FCF Per Share	-$1.53

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-16,006.15%
Pretax Margin	-9,733.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-138.29%
Shareholder Yield	-138.29%
Earnings Yield	-22.50%
FCF Yield	-28.01%

Analyst Forecast

The average price target for SER is $13.00, which is 142.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	142.31%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1